Chronic Myeloproliferative Disorders
Editat de Tariq Mughal, John M. Goldmanen Limba Engleză Hardback – 27 aug 2008
This title comprehensively covers chronic myeloid leukemia and Ph-negative chronic myeloproliferative disorders and is an essential resource for all practitioners in Hematologic Oncology.
Preț: 707.15 lei
Preț vechi: 848.47 lei
-17% Nou
Puncte Express: 1061
Preț estimativ în valută:
135.33€ • 140.58$ • 112.41£
135.33€ • 140.58$ • 112.41£
Comandă specială
Livrare economică 13-27 ianuarie 25
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780415415989
ISBN-10: 0415415985
Pagini: 272
Ilustrații: 34 tables, 14 color halftones and 18 color line drawings
Dimensiuni: 189 x 246 x 18 mm
Greutate: 1.35 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
ISBN-10: 0415415985
Pagini: 272
Ilustrații: 34 tables, 14 color halftones and 18 color line drawings
Dimensiuni: 189 x 246 x 18 mm
Greutate: 1.35 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Public țintă
Professional ReferenceCuprins
I. Bcr/Abl Positive Chronic Myeloproliferative Disorders. 1. Epidemiology and history. 2. Cytogenetics and molecular biology. 3. Risk stratification. 4. Clinical features. 5. Non-transplant treatment options. 6. Allogeneic stem cell transplantation. 7. Autologous stem cell transplantation. 8. Vaccines. 9. A therapeutic algorithm and concluding remarks. II. Bcr/Abl Negative Chronic Myeloproliferative Disorders. 10. Epidemiology and history. 11. Cytogenetics and molecular biology. 12. Risk stratification. 13. Clinical features. 14. Non-transplant treatment options. 15. Transplantation options. 16. A therapeutic algorithm and concluding remarks.
Notă biografică
TARIQ I MUGHAL is Professor of Medicine and Haematology/Oncology at the University of Texas Southwestern Medical School, Dallas, USA and Consultant Haematologist at Guy’s & St Thomas’ Hospitals, London UK
JOHN M. GOLDMAN is Professor of Haematology at Imperial College London, Hammersmith Hospital, London, UK.
JOHN M. GOLDMAN is Professor of Haematology at Imperial College London, Hammersmith Hospital, London, UK.
Descriere
With the new classification of chronic myeloproliferative disorders, and the rise of interest in molecularly targeted therapies, this timely text brings together international experts on the topic to discuss the current technologies and their implications for the treatment of patients.
This title comprehensively covers chronic myeloid leukemia and Ph-negative chronic myeloproliferative disorders and is an essential resource for all practitioners in Hematologic Oncology.
This title comprehensively covers chronic myeloid leukemia and Ph-negative chronic myeloproliferative disorders and is an essential resource for all practitioners in Hematologic Oncology.